ispronicline: Clinical Trials

5 trials of ispronicline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5

Follow ispronicline: new trials by email Literature Review of ispronicline trials Research Report on ispronicline

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
Donepezil, AZD3480 - Alzheimer's Disease
Phase 2CompletedTargacept Inc.3862011-10-012015-06-03
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Placebo, AZD3480 - ADHD
Phase 2CompletedAstraZeneca242008-05-012009-10-30
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
AZD3480 - Schizophrenia
Phase 2CompletedAstraZeneca4002007-08-012008-11-25
Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
AZD3480, Donepezil - Alzheimer Disease
Phase 2CompletedAstraZeneca6592007-07-012014-07-23
A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)
ispronicline (nicotinic acetylcholine receptor agonist) - Age-Related Memory Disorders
Phase 2CompletedTargacept Inc.1742005-01-012008-07-18

Conditions studied

Alzheimer Disease (2)  ·  Dementia (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Cognition Disorders (1)  ·  Memory Disorders (1)  ·  Schizophrenia (1)

Sponsors

AstraZeneca (3)  ·  Targacept Inc. (2)

Countries

United States (4)  ·  Canada (2)  ·  Czechia (2)  ·  Romania (2)  ·  Austria (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Germany (1)  ·  Russia (1)  ·  Slovakia (1)  ·  Spain (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Larry Rodichok, MD (1)  ·  Pierre Tariot, MD (1)

Results publications

PMID 20542923, PMID 23856296